The interstitial lung disease (ILD) program at The Ohio State University Wexner Medical Center comprises nurses, advanced practice providers and physicians who specialize in the diagnosis and treatment of patients with interstitial lung disease. Interstitial lung disease is a general term to describe a large group of diseases that negatively affect the lung tissue through varying degrees of inflammation and scarring. We employ a multidisciplinary approach in collaboration with expert thoracic radiologists and pathologists to provide comprehensive personalized treatment plans tailored to each individual’s goals through education, pulmonary rehabilitation and medications. In many cases, we closely collaborate with specialists in rheumatology, cardiology, gastroenterology, thoracic surgery, transplant pulmonology and palliative care medicine. Our clinical faculty have various practice locations to meet your needs.
In addition to our clinical activities, we have a robust research program dedicated to basic science discovery and understanding of the underlying mechanisms that contribute to the development and progression of interstitial lung diseases, the bench-to-bedside translation of discoveries to patient care. Our clinical research program includes partnerships with industry and other academic medical centers to evaluate the effectiveness of emerging therapies and to identify new strategies to improve the lives of patients with ILD in the future.
A key component of our program is our patient and family support. As a member of the Pulmonary Fibrosis Foundation, the nation’s leading pulmonary fibrosis advocacy and education program, we are committed to advancing and improving the care of ILD patients. With interactive meetings in which patients and their families can meet with members of our team, we discuss a broad range of topics selected to educate, assist and advise patients living with interstitial lung disease.